Balanced news tone
News Sentiment
688331 sentiment intelligence
RemeGen Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
71/100 classification confidence.
directly relevant articles
high-authority source matches
-13.4% over one week, +1.3% over four weeks, trend active, and materially above fair value.
Price to book forward of RemeGen Co. Ltd. Class A – SSE:688331
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Price to book forward of RemeGen Co. Ltd. Class A – SSE:688331
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 11:37
- Source
- TradingView
RemeGen scores out-licensing triple play with AbbVie deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 22 Jan 2026 08:00
- Source
- thebambooworks.com
RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Aug 2025 07:00
- Source
- PR Newswire
REMEGEN CO., LTD. - H SHARES (9995) - stock price, quote, history
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Nov 2020 08:00
- Source
- hkex.com.hk